The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner
Abstract Recombinant adeno-associated viral vectors (rAAVs) are among the most commonly used vehicles for in vivo based gene therapies. However, it is hard to predict which AAV capsid will provide the most robust expression in human subjects due to the observed discordance in vector-mediated transdu...
Main Authors: | Adriana Gonzalez-Sandoval, Katja Pekrun, Shinnosuke Tsuji, Feijie Zhang, King L. Hung, Howard Y. Chang, Mark A. Kay |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-38106-3 |
Similar Items
-
Improving retinal vascular endothelial cell tropism through rational rAAV capsid design.
by: Ramesh Periasamy, et al.
Published: (2023-01-01) -
Differential effects of two MRI contrast agents on the integrity and distribution of rAAV2 and rAAV5 in the rat striatum
by: Sue Osting, et al.
Published: (2014-01-01) -
Partial genome content within rAAVs impacts performance in a cell assay-dependent manner
by: Bryan Troxell, et al.
Published: (2023-09-01) -
Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method
by: Renuka Rao, et al.
Published: (2022-07-01) -
Subcellular distribution of the rAAV genome depends on genome structure
by: Nuri Oh, et al.
Published: (2023-10-01)